infection

Introduction to Infections

• Key Issues:

  • Significant causes of death and morbidity in populations.

  • Reemergence of diseases previously thought controlled (e.g., polio).

  • Emergence of new infections (e.g., $COVID-19$ pandemic starting in $2019$).

  • Rise in antimicrobial resistance (AMR).

Symbiotic Relationships Between Humans and Microorganisms

• Symbiosis: Describes the relationship between humans and surrounding microorganisms.

• Definition: Generally implies cohabitation that benefits the host.

  • Example: Normal flora in the bowel aids digestion, providing vitamins to human hosts.

• Subcategories of symbiosis:

  • Mutualism: Both human and microorganism benefit.

  • Example: Certain strains of E. coli produce Vitamin $K$ for human hosts.

  • Commensalism: Microorganism benefits, but human is unaffected.

  • Example: Staphylococcus epidermis feeds on dead skin cells without harmful effects to humans.

  • Pathogenic Relationships: Microorganisms benefit at the host's expense.

  • Example: E. coli in the urinary tract can cause inflammation.

  • Opportunism: Normally benign microorganisms become pathogenic under certain conditions.

  • Example: Pneumocystis pneumonia in immunocompromised individuals (e.g., those with $HIV$).

  • Candida albicans can overgrow and cause infections in immunosuppressed hosts.

Pathogenesis and Factors in Pathogenicity

• The human body provides a conducive environment for pathogens (warmth, moisture).

• Key definitions related to microorganisms:

  • Communicability: Ability of a microorganism to spread from person to person.

  • Immunogenicity: Capacity of a pathogen to provoke an immune response.

  • High immunogenicity may cause harmful immune reactions (e.g., tuberculosis).

  • Infectivity: Ability of a pathogen to invade and multiply within the host.

  • Mechanism of Action: How a pathogen damages tissues.

  • Pathogenicity: Capability to produce disease; relates to survival and means of transmission.

  • Portal of Entry: Routes through which pathogens infect hosts (e.g., inhalation, ingestion, vectors).

  • Toxigenicity: Ability to produce toxins harmful to humans.

  • Virulence: Level of severity of organisms; varies among pathogens.

Transmission of Pathogens

• Direct Transmission: Transfers pathogens through direct contact.

  • Example: Impetigo in children due to skin contact.

• Indirect Transmission: Pathogens transferred via fomites (inanimate objects).

  • Importance of hand hygiene and disinfecting surfaces to prevent this type.

• Various routes of indirect transmission:

  • Respiratory Transmission: Through droplets when coughing/sneezing (common colds, flu, $COVID-19$).

  • Fecal-Oral Transmission: Ingestion of contaminated food/water (e.g., salmonella, cholera).

  • Vector-Borne Transmission: Pathogens transmitted via insects (e.g., malaria through mosquitoes).

  • Horizontal Transmission: Involves exposure via body fluids (e.g., $HIV$ via contaminated needles or sexual contact).

  • Vertical Transmission: Pathogen transmission from mother to offspring (e.g., through placenta, breast milk).

Stages of Infection

• Colonization: Pathogens must survive and replicate in the host.

• Invasion: Pathogens penetrate tissues to spread and cause damage.

• Incubation Period: Time from exposure to the appearance of symptoms.

  • Examples: Cold ($2-5$ days); Tuberculosis ($6-24$ months).

• Prodromal Phase: Mild symptoms as the pathogen multiplies without specific localization.

• Invasion (Acute Illness Stage): Rapid pathogen growth and distinct symptoms emerge, allowing for diagnosis.

• Convalescence: Immune system successfully clears the pathogen; symptoms reduce.

  • Example: Herpes simplex may cycle between active and latent phases.

Classification of Diseases by Prevalence

• Endemic: Constant presence of a disease within a population (e.g., annual influenza).

• Epidemic: Substantial increase in disease prevalence within a localized area.

• Pandemic: Global spreading of infectious disease significantly; characterized by widespread social impact (e.g., $COVID-19$).

Classes of Infectious Microorganisms

• Bacteria:

  • Prokaryotes lacking a nucleus; can be aerobic or anaerobic.

  • Shapes: Cocci (spherical), Bacilli (rod-shaped), Spirochetes (spiral).

  • Gram Positive vs. Gram Negative:

  • Difference in cell wall structure affects antibiotic susceptibility.

  • Factors influencing virulence include adherence through fimbriae, motility through flagella, and production of toxins.

• Viruses:

  • Simplistic structure requiring living cells for replication ($RNA$ or $DNA$).

  • Can cause diseases like common colds, hepatitis, and certain cancers (e.g., $HPV$).

  • Vaccination is key for prevention vs. viral infections.

  • Types of vaccines include live-attenuated, inactivated, $mRNA$, and subunit vaccines.

• Fungi:

  • Eukaryotic microorganisms with significant health implications.

  • Examples of infections: Candidiasis, Aspergillosis, Pneumocystis pneumonia.

  • Recognized as mycosis, transmitted via inhalation or direct contact.

Antimicrobial Resistance

• Growing concern with estimated $35,000$ deaths annually in the $U.S.$ linked to antibiotic resistance.

• Regular use of antibiotics should be justified to minimize resistance development.

• Importance of educating patients on appropriate antibiotic use to preserve normal flora and prevent infections.

Summary of HIV/AIDS

• $HIV$ is a retrovirus that leads to $AIDS$ (acquired immune deficiency syndrome).

• Transmission methods: Blood, sexual contact, and vertical transmission (from mother to child).

• Clinical stages of HIV:

  • Acute infection.

  • Clinical latency.

  • Progression to $AIDS$ characterized by a decrease in $CD4$ T-helper cells and increased opportunistic infections.

• Treatment involves antiretroviral therapy but currently no cure exists.

Conclusion

• Dr. Jisba highlights the intricate relationship between infections, the immune response, and treatment principles.

• The essential role healthcare providers play in managing and preventing infectious diseases in clinical practice is emphasized.